The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies

In conclusion, this meta-analysis showed a high clinical RR of CD19-CAR-T cell–based immunotherapy in patients with refractory B-cell malignancies.
Source: Cytotherapy - Category: Cytology Source Type: research